Patent Licensing Details

Technology reference number: 201611031991
First Published on:
Title of the technology: Mammalian cell lines for enhanced production of Japanese encephalitis virus, the method to produce and uses thereof
Technology Brief: Mutant mammalian cell lines for enhanced production of Japanese encephalitis virus
Potential Application(s): The JEV produced from using these cell lines can be used as immunogen in JE vaccine or as an antigen in JE diagnosis.
Advantage(s): Enhanced production of Japanese encephalitis virus
IP status: Provisional patent application filed
Development status: Proof-of-Concept stage
Researcher(s):
Owner(s): THSTI
Last date to receive interest:
Image(s):

Click on image for full view